July 21, 2017
Pharming Group in repayment of bridge finance on unchanged terms
Pharming Group N.V. has completed the replacement of its recently announced $100 million bridge finance with OrbiMed Advisors with a $100 million permanent facility agreement with OrbiMed Advisors.